The integration enables streaming of the patient’s NOL-Nociception Level Index® data to EHRs, supporting personalized analgesia in surgery and critical care.
US, ISRAEL, July 7, 2026 /EINPresswire.com/ — Objective pain-monitoring data obtained via Medasense’s PMD-200™ patient monitor and its NOL-Nociception Level Index® can now be documented and accessed alongside other patient data within hospital electronic health records (EHRs) and clinical information systems, giving clinicians a more complete view of patient status and supporting data-driven analgesia management. Medasense Biometrics announced today that the new capability is enabled through the integration of its PMD-200™ monitor with Philips Capsule Medical Device Information Platform (MDIP). The PMD-200 is the first and only FDA-authorized monitor that gives clinicians an objective, real-time measure of a patient’s pain response under general anesthesia and sedation — enabling more precise, personalized analgesia, helping to avoid both under- and over-medication and improve perioperative outcomes.